Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer
Universität Hamburg · University Medical Center Hamburg-Eppendorf · +12 more institutions
Abstract
Abstract Pancreatic ductal adenocarcinoma (PDAC) is expected to be the second most deadly cancer by 2040, owing to the high incidence of metastatic disease and limited responses to treatment 1,2 . Less than half of all patients respond to the primary treatment for PDAC, chemotherapy 3,4 , and genetic alterations alone cannot explain this 5 . Diet is an environmental factor that can influence the response to therapies, but its role in PDAC is unclear. Here, using shotgun metagenomic sequencing and metabolomic screening, we show that the microbiota-derived tryptophan metabolite indole-3-acetic acid (3-IAA) is enriched in patients who respond to treatment. Faecal microbiota transplantation, short-term dietary…
Citation impact
- FWCI
- 69.65
- Percentile
- 100%
- References
- 51
Authors
31- JTJoseph TintelnotCorresponding
Universität Hamburg, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg
- YXYang Xu
Universität Hamburg, University Medical Center Hamburg-Eppendorf
- TRTill Robin Lesker
Helmholtz Centre for Infection Research
- MSMartin Schönlein
Universität Hamburg, University Medical Center Hamburg-Eppendorf
- LKLeonie Konczalla
Universität Hamburg, University Medical Center Hamburg-Eppendorf
Topics & keywords
- Cancer research
- Pancreatic cancer
- Cancer
- Gut flora
- Biology
- Metabolite
- Downregulation and upregulation
- Chemotherapy
- Zero hunger
Funding
- ECEuropean CommissionAwards: 800924, 715271, 865466
- DFDeutsche ForschungsgemeinschaftAwards: SFB841, 390874280, SI1549/4-1, EXC 2155, 467261817, 405344257
- VFVolkswagen Foundation
- BFBundesministerium für Bildung und ForschungAwards: EXC 2155, 01KD2206A/SATURN3, BMBF; 01KD2206A/SATURN3, SATURN3
- NNNovo Nordisk
- AIAssociazione Italiana per la Ricerca sul CancroAward: 800924
- DKDeutsche KrebshilfeAwards: 70114815, 390874280
- NNNovo Nordisk FondenAward: NNF21OC0066381
- DKDeutschen Konsortium für Translationale Krebsforschung
- UHUniversitätsklinikum Hamburg-Eppendorf